Form Type:  SC 13G/A
Filing Date:  2/14/2023 
CIK:  0000885590 
Address:  2150 ST. ELZEAR BLVD. WEST
City, State, Zip:  QUEBEC,  H7L 4A8 
Telephone:  514-744-6792 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
0.03 (0.37%)  
Trade Time: 
Jun 02  
Market Cap: 
Trade BHC now with 

© 2023  
Description of Business
Bausch Health Companies Inc. ("we", "us", "our", the "Company" or "Bausch Health") is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology ("GI") and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter ("OTC") products and medical aesthetic devices and, through its majority ownership of Bausch + Lomb Corporation ("Bausch + Lomb"), branded, and branded generic pharmaceuticals, OTC products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment) in the therapeutic area of eye health. The Company's products are marketed directly or indirectly in approximately 100 countries. Our portfolio of products falls into five reportable segments: (i) Salix, (ii) International, (iii) Solta Medical, (iv) Diversified Products and (v) Bausch + Lomb.
Register and access this filing in:     

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.